Back to top
more

Tempus AI, Inc. (TEM)

(Delayed Data from NSDQ)

$72.69 USD

72.69
15,928,284

+6.04 (9.06%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $71.94 -0.75 (-1.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 247)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

TEM Stock Rises on Launch of AI-Powered Health Concierge App

Tempus AI announces the launch of olivia, an AI-enabled personal health concierge app designed to revolutionize patient care and engagement nationwide.

Zacks Equity Research

TEM Stock Declines Following Preliminary Q4 Sales Miss

Tempus reports strong 2024 growth and unveils a bold 2025 outlook with 75% revenue growth and innovative diagnostics.

Zacks Equity Research

Tempus AI Stock Falls Despite Collaboration Announcement With Genialis

TEM announces a collaboration with Genialis to develop new RNA-based algorithms across cancer types.

Zacks Equity Research

The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS

Tempus AI, iRhythm Technologies and SOPHiA GENETICS are part of the Zacks top Analyst Blog.

Urmimala Biswas headshot

Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now?

TEM's cutting-edge product lines and strategic plans are positioning it for long-term success.

Indrajit Bandyopadhyay headshot

5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More

Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care.

Debanjana Dey headshot

Tempus AI Stock Plunges 28.9% in Three Months: What's Next?

TEM is enhancing its offerings and expanding the breadth of products and services to improve patient care. However, macro challenges are likely to hurt its performance.

Zacks Equity Research

Will Ambry Genetics Acquisition Drive Tempus AI's Prospects?

TEM acquires Ambry Genetics, expanding its testing portfolio and redefining precision medicine.

Zacks Equity Research

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

TEM's third-quarter results reflect strong segmental performance. However, the company continues to incur losses at the operational level.

Zacks Equity Research

Tempus Stock Up Following Collaboration Expansion in Oncology R&D

TEM's latest expanded partnership is likely to leverage multimodal real-world datasets and biological model systems in oncology R&D.